European equities traded in the US as American depositary receipts were rising on Wednesday morning, up 0.5% to 1,497.69 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by pharmaceutical company Addex Therapeutics (ADXN) and advertising company Criteo (CRTO), which rose 5.1% and 2% respectively.
They were followed by energy company Eni (E), up 1.4%.
The decliners from continental Europe were led by biotech companies Abivax (ABVX) and Evaxion (EVAX), which fell 2.9% and 2% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Verona Pharma (VRNA) and biotech firm Bicycle Therapeutics (BCYC), which gained 4.8% and 3.9% respectively.
They were followed by biotech company Barinthus Biotherapeutics (BRNS), which added 2%.
The decliners from the UK and Ireland were led by biotech firms Akari Therapeutics (AKTX) and Autolus Therapeutics (AUTL), which dropped 3.5% and 3.2% respectively.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.